Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
, 45 (4), 537-9

Clinical Relevance of Proteus Mirabilis in Hospital Patients: A Two Year Survey

Affiliations
Clinical Trial

Clinical Relevance of Proteus Mirabilis in Hospital Patients: A Two Year Survey

C de Champs et al. J Antimicrob Chemother.

Abstract

A retrospective study was performed on 1072 non-duplicate isolates of Proteus mirabilis, taken in the period April 1996 to March 1998, and on 100 patient charts randomly selected during the same period. P. mirabilis isolates accounted for 7.7% of Enterobacteriaceae. The isolates were predominantly from urine (70.2%); of the total, 38.0% were penicillinase-producing isolates, 6.9% were extended-spectrum beta-lactamase (ESBL)-producing isolates and 3.6% produced inhibitor-resistant beta-lactamase (IRB). ESBL-producing isolates were observed in long-stay and intensive care and IRB-producing isolates in paediatric units. Of the 95 patients whose charts were examined, 69 had a confirmed infection, which in 42 cases was nosocomial.

Similar articles

See all similar articles

Cited by 15 articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback